has subject area Antibodies, Monoclonal, Humanized Antineoplastic Agents Antineoplastic Combined Chemotherapy Protocols Azetidines Cost-Benefit Analysis Humans Immunotherapy Melanoma Neoplasm Metastasis Piperidines Progression-Free Survival Proto-Oncogene Proteins B-raf Quality-Adjusted Life Years Vemurafenib